BackFoghorn Therapeutics Overview
Foghorn Therapeutics Inc

Foghorn Therapeutics Target Price

Analysts' average 12-month price target for Foghorn Therapeutics is $4.

Get informed when a big investor buys or sells

+ Follow

Share Price

$2.1

Average Target Price

$4.0090.5% upside

5 analysts in the last 4 months

High: $5 | Low: $2

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-10-13Evercore ISI$342.9% upsideOpen
2026-10-02H.C. WainwrightAndrew Fein$5138.1% upsideOpen
2026-10-02Guggenheim$5138.1% upsideOpen
2026-10-02WedbushRobert Driscoll$24.8% downsideOpen
2026-10-01Stifel NicolausLaura Prendergast$5138.1% upsideOpen
2026-02-17Jefferies$12471.4% upsideOpen
2025-12-18BTIG$11423.8% upsideOpen
2025-12-03Stifel Nicolaus$12471.4% upsideOpen
2024-12-17H.C. WainwrightFoghorn Therapeutics to $$13519% upsideOpen
2024-09-24Morgan StanleyVikram Purohit$9328.6% upsideOpen
2024-08-19Evercore ISIGavin Clark-Gartner$20852.4% upsideOpen
2023-01-05BMO Capital$20852.4% upsideOpen
2022-11-21Morgan Stanley$14566.7% upsideOpen
2022-08-23Morgan StanleyVikram Purohit$15614.3% upsideOpen

Foghorn Therapeutics (FHTX) FAQ

Foghorn Therapeutics (FHTX) currently reports a target price of $4. Use the charts on this page to explore Foghorn Therapeutics's target price history and peer comparisons.

Analysts' average 12-month price target for Foghorn Therapeutics is $4, about 90.5% upside from the current share price of $2.1. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $4, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Foghorn Therapeutics, and consider following FHTX for alerts when major investors trade the stock.

Foghorn Therapeutics is classified in the Healthcare sector. On target price, it currently shows $4. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing FHTX with unrelated industries.